DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Recruiting now NCT07717437
Run by Maastricht University Medical Center · for 18 and older · All sexes
What this study is about
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Who can join (things the study team will check)
✅ You may be able to join if…
- Patients who have undergone PVE/HVE or technical variations on this procedure
- 18 Years and older
- Men and women
Where this trial is running
- Rush University Medical Center, Chicago, Illinois, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Monash Medical Centre, Clayton, Victoria, Australia
- MedUni Wien, Vienna, State of Vienna, Austria
- Social Center South (Klinik Favoriten), Vienna, State of Vienna, Austria
- UZ Antwerpen, Edegem, Antwerpen, Belgium
- Erasmus Hospital, Anderlecht, Brussels Capital, Belgium
- CHU de Liège, Liège, Liège, Belgium
- UZ Gent, Ghent, Oost-Vlaanderen, Belgium
- Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada
- The Ottawa Hospital, Ottawa, Ontario, Canada
+ 19 more sites.
Who to contact
Fenna Van der Zijden, Dr. · +316 40911632 · fenna.van.der.zijden@mumc.nl
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07717437.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.